Leaflet CYCLOVITA 400mg ovules


Indicated for: disorders associated with progesterone deficiency

Route of administration: vaginal

Substance: progesterone (progestogen)

ATC: G03DA04 (Genito urinary system and sex hormones | Progestogens | Pregnen (4) derivatives)

Progesterone is a natural hormone used in the treatment of menstrual disorders, infertility, and other conditions associated with progesterone deficiency. It plays a crucial role in regulating the menstrual cycle and maintaining pregnancy.

The medication is administered orally, by injection, or as a vaginal gel, as directed by a doctor. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as headaches, nausea, or breast tenderness. It is important to inform the doctor of any unusual symptoms.

Common side effects include headaches, nausea, and breast tenderness. In rare cases, severe reactions such as thrombosis or allergic reactions may occur. Patients should be informed of these risks before use.

General data about CYCLOVITA 400mg

  • Substance: progesterone
  • Date of last drug list: 01-03-2023
  • Commercial code: W69410001
  • Concentration: 400mg
  • Pharmaceutical form: ovules
  • Quantity: 12
  • Product type: original
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: GEDEON RICHTER PLC. - UNGARIA
  • Holder: GEDEON RICHTER PLC. - UNGARIA
  • Number: 14278/2022/01
  • Shelf life: 4 years

Concentrations available for progesterone

  • 1%
  • 100mg
  • 10mg/g
  • 200mg
  • 25mg
  • 400mg
  • 80mg/g